SG Americas Securities
DGX icon

SG Americas Securities’s Quest Diagnostics DGX Stock Holding History

SG Americas Securities’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-32,800
Closed -$16K – 2670
2014
Q2 		$16K Buy
+32,800
New +$1.92M ﹤0.01% 2463

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

SG Americas Securities's DGX Position: Q1 2026 in Review

SG Americas Securities increased its Quest Diagnostics (DGX) stake by 21% in Q1 2026, buying an estimated $7.31M and bringing the position to 217,286 shares worth $42.6M. The position accounts for 0.05% of the portfolio, ranked #314.

SG Americas Securities first reported a position in DGX in Q2 2013 and has held it in 51 quarters since. 1,065 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • SG Americas Securities held 217,286 shares of Quest Diagnostics worth $42.6M as of Q1 2026.
  • SG Americas Securities bought 37,633 Quest Diagnostics shares in Q1 2026, an estimated $7.31M.
  • Quest Diagnostics made up 0.05% of SG Americas Securities's portfolio in Q1 2026, its #314 holding.
  • SG Americas Securities first reported a position in Quest Diagnostics in Q2 2013 and has held it in 51 quarters since.
  • 1,065 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.